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ABSTRACT 
Giant Cell Arteritis (GCA) is the most common vasculitis affecting the elderly.  Archived formalin 
fixed paraffin embedded (FFPE) temporal artery biopsy (TAB) specimens potentially represent a 
valuable resource for large-scale genetic analysis of this disease.   
FFPE TAB samples were obtained from 12 patients with GCA. Extracted TAB DNA was assessed 
by real time PCR (RT-PCR) prior to restoration using the Illumina HD FFPE Restore Kit. Paired 
FFPE-blood samples were genotyped on the Illumina OmniExpress FFPE microarray. 
The FFPE samples which passed stringent QC measures had a mean genotyping success of >97%. 
When compared to their matching peripheral blood DNA, the mean discordant heterozygote and 
homozygote SNP calls were 0.0028 and 0.0003, respectively, which is within the accepted tolerance 
of reproducibility. 
This work demonstrates that it is possible to successfully obtain high quality microarray-based 
genotypes FFPE TAB samples and that this data is similar to that obtained from peripheral blood.  
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Giant Cell Arteritis (GCA) is the most common inflammatory vasculitis affecting elderly people. 
The incidence of GCA increases progressively after the age of 50 years, and it is more common in 
women 1. Prevalence of GCA varies depending on ethnic background, with the highest reported 
incidence in northern Europe and people of Scandinavian descent2. GCA typically affects medium 
and large arteries of the head and neck. Patients can exhibit a variety of ischemic symptoms 
including headache, jaw claudication, and transient visual obscurations 3. Involvement of the 
ophthalmic artery can cause irreversible visual loss. GCA is also a potentially life threatening 
disease as it can lead to stroke and aortic dissection.  
 
Currently, there are no specific biochemical markers used to identify this disease, though elevated 
acute phase proteins, reflected by an increased erythrocyte sedimentation rate (ESR) or C-reactive 
protein (CRP) level in conjunction with a compatible clinical picture suggest the diagnosis. 
Diagnosis of GCA is confirmed histologically by temporal artery biopsy (TAB). TAB is included in 
the American College of Rheumatology 1990 criteria for the classification of GCA11 and remains 
the current gold standard for diagnosis.  
 
To date, studies investigating the genetic architecture of GCA have been limited4. However, several 
small-scale studies have demonstrated an association with MHC class II genes, most notably HLA-
DRB1*045-6. Significant associations have also been reported for a number of inflammatory 
cytokines and other small molecules, including but not limited to TNFa2,7 IL-10,8 NOS2,9  and 
VEGF10. A comprehensive genome-wide association study (GWAS) of GCA confirming these 
associations and potentially identifying additional risk loci has yet to be published.  
 
Retrospective recruitment of a large cohort of GCA patients for genetic analysis is challenging. As 
the mean age of onset of GCA is over 75 years, the primary reason for this issue is that many of the 
elderly patients live in residential care and are hence difficult to locate, are deceased, or have major 
medical co-morbidities, precluding participation. To overcome this difficulty in recruitment, we 
investigated the potential for extracting high quality DNA directly from archived Formalin-Fixed 
Paraffin-Embedded (FFPE) TABs. Direct comparisons were made to DNA extracted from whole 
blood. 
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METHODS 
Patients 
Ethics approval for this study was obtained from the relevant committees at the Royal Victorian 
Eye and Ear Hospital (08/823H) and St Vincent’s Hospital (026/09), Melbourne, Australia. All 
study participants provided written, informed consent. Twelve FFPE TAB samples, stored for 
between three and five years, were obtained from patients with histologically confirmed GCA. 
These patients also had peripheral blood samples collected for peripheral leucocyte DNA extraction.  
 
TAB DNA Extraction 
Ten 10µm sections of each TAB sample were collected and deparaffinised using xylene. The tissue 
samples were treated with digestion buffer containing proteinase K (1mg/mL proteinase K, 0.5% 
Tween 20, 100 mM NaCl, 1 mM EDTA, 50 mM Tris HCl pH 7.5) for 24 hours at 55oC. DNA was 
isolated from the cell lysates by performing two phase-separation steps, using 
Phenol:Chloroform:Isoamyl Alcohol 25:24:1 (Sigma, St. Louis, MO) followed by Chloroform only. 
DNA was precipitated with isopropanol using a glycogen carrier.  
 
DNA QC Analysis 
Double stranded DNA was quantified using Quant-iTTM Picogreen® (Life Technologies, Carlsbad, 
CA). The quality of the extracted FFPE TAB DNA was evaluated by real time PCR (RT-PCR) 
using the Illumina Infinium HD FFPE QC Kit (San Diego, CA). Samples which passed quality 
control proceeded to DNA restoration using the Illumina FFPE Restore Kit.  
 
Genotyping 
All 24 samples were genotyped on Illumina Infinium HD FFPE OmniExpress arrays as per 
manufacturer’s instructions. The raw fluorescence intensity data was normalized and clustered for 
each sample using Illumina Genome Studio (v. 2011.1). Genotypes were called using the standard 
Illumina HumanOmniExpress FFPE cluster file.   
 
Genotyping quality control, including gender concordance, missing rates, heterozygosity, 
duplicated individuals and genotyping concordance between FFPE TAB and blood derived DNA, 
were assessed using PLINK (v1.07) and R (v 2.15.1). The correlation between RT-PCR results and 
genotyping missing rate was determined by linear regression.  
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RESULTS AND DISCUSSION  
DNA of sufficient quantity for microarray genotyping was extracted from all 12 FFPE TAB 
samples. RT-PCR analysis indicated that all FFPE TAB samples met the manufacturer’s criteria (a 
RT-PCR Δ cycle threshold (CT) value of <5) for proceeding to restoration and genotyping.  
 
Using the Illumina OmniExpress FFPE cluster file all peripheral blood DNA samples were 
successfully genotyped with call rates >98%. The threshold for successful genotyping was set to 
95% for the FFPE TAB derived samples and using this cutoff, eight of the 12 samples passed initial 
genotyping quality control (QC). These eight samples had a ΔCT value <2 and a mean call rate of 
97.4%. The remaining four samples with genotyping call rates <95% had ΔCT value >2 and a mean 
call rate of 89.2%. Linear regression analysis demonstrated a positive correlation between genotype 
missing rate and ΔCT values (y = 0.034x - 0.0011, R² = 0.4308, p=0.02) (Figure 1).  
 
The GenCall (GC) scores and standard deviation of the logR ratios (log R Dev) as calculated by 
Genome Studio were also utilized as QC metrics. A GC score is a value between zero and one 
which reflects the reliability of each genotype call; scores >0.7 indicate high quality genotypes.  
The mean GC score of the eight FFPE samples which passed QC was 0.7370 while the peripheral 
blood derived samples had a comparable result of 0.7583. The log R Dev is based on normalized 
fluorescence intensity data and is a measure of reproducibility and signal-to-noise ratio. The 
average log R Dev of the eight FFPE samples was 0.50, which is consistent with values obtained 
using DNA from other sources such as blood or saliva (0.40) (Table 1).  
 
All of the called genotypes for the eight FFPE samples which passed a stringent RT-PCR ΔCT <2 
cutoff were compared to their matching peripheral blood DNA genotypes, the mean discordant 
heterozygote and mean discordant homozygote SNP calls were 0.0028 (range: 0.0007-0.0068) and 
0.0003 (range: 0.0002-0.0006), respectively (Table 1).  
 
 
In this study we directly compared genome-wide genotyping of FFPE and peripheral blood DNA 
samples obtained from the same patients. FFPE tissue specimens, such as TAB, hold an abundance 
of invaluable information for studies of human disease such as GCA. Regrettably, formalin fixation 
procedures and subsequent storage conditions result in nucleic acid degradation, DNA cross-linking 
and base modification12. Consequently, FFPE samples have previously yielded highly degraded 
DNA leading to sub-optimal performance in most microarray genotyping studies. Recent advances 
in DNA recovery and restoration methodologies specifically targeted towards FFPE specimens 
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have; however, enabled extraction of DNA of sufficient quality to be accurately genotyped using 
the microarray genotyping technology employed in GWAS. 
 
Our results demonstrate that employing rigorous DNA QC thresholds, such as a ΔCT cutoff values 
of <2 for RT-PCR QC prior to DNA restoration, will dramatically improve genotyping quality and 
success rate. As expected, a slight increase in the genotype missing rate was observed in the FFPE 
derived samples; however, the number of discordant genotypes between the sample types is very 
low indicating that this methodology can produce robust and reproducible results.  The rate of 
discordance in heterozygous genotype calls was slightly greater than homozygous calls. This 
finding is likely to be due to DNA damage such as deletions, introduced during the specimen 
fixation process, resulting in an under-representation of alternate alleles. Nonetheless, for the 
samples passing a stringent RT-PCR ΔCT <2 the level of discordance is consistent with that 
previously been described by Hong et al. who reported a total discordance rate of 0.0013 for intra-
laboratory technical replicates genotyped on Illumina Omni 1M microarrays13. 
 
In summary, GCA is a complex disease and studies investigating its genetic architecture have been 
limited by their lack of statistical power, with the relatively late age of diagnosis contributing to the 
difficulties in recruiting large case cohorts. However, given that diagnosis is confirmed by TAB, 
archived FFPE histopathological specimens represent a valuable resource for large-scale molecular 
analysis. Adopting our QC FFPE-restoration thresholds will enable the large-scale ascertainment 
and utilization of samples from GCA patients for potential use in genome-wide association study, 
thereby circumventing the retrospective recruitment challenge for GCA. Ultimately this 
methodology is not only relevant to GCA but to other diseases requiring histological analysis and 
where recruitment of patients has proven difficult.  
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Table 1. Comparison of DNA extracted from archived FFPE temporal artery specimens and peripheral blood.  
 
 FFPE derived DNA Blood derived DNA FFPE v Blood 
Patient  RT-PCR ΔCT 
Total 
Missing 
Genotypes 
Mean 
GC 
Score 
LogR 
Dev 
Total 
Missing 
Genotypes 
Mean GC 
Score 
LogR 
Dev 
Discordant 
Heterozygous 
Genotypes 
Discordant 
Homozygous 
Genotypes 
1 0.54 0.0192 0.7441 0.4831 0.0097 0.7560 0.4356 0.0011 0.0003 
2 0.64 0.0154 0.7486 0.4735 0.0086 0.7572 0.4262 0.0007 0.0002 
3 0.64 0.0144 0.7508 0.4544 0.0071 0.7600 0.4075 0.0008 0.0002 
4 0.73 0.0363 0.7244 0.5637 0.0121 0.7538 0.4000 0.0042 0.0005 
5 1.03 0.0369 0.7237 0.5541 0.0078 0.7591 0.4122 0.0059 0.0006 
6 1.40 0.0210 0.7431 0.4614 0.0101 0.7568 0.3851 0.0013 0.0002 
7 1.43 0.0228 0.7397 0.5145 0.0086 0.7578 0.4308 0.0018 0.0003 
8 1.77 0.0394 0.7215 0.5670 0.0126 0.7530 0.4072 0.0068 0.0005 
9 2.29 0.1797 0.5838 0.5944 0.0066 0.7612 0.3938 0.1472 0.0049 
10 2.36 0.0626 0.6992 0.5358 0.0058 0.7639 0.3128 0.0182 0.0007 
11 2.77 0.1190 0.6401 0.6827 0.0084 0.7595 0.3653 0.0762 0.0033 
12 3.52 0.0712 0.6834 0.6594 0.0059 0.7617 0.3854 0.0257 0.0015 
 
Abbreviations: FFPE, formalin-fixed paraffin embedded; CT, cycle threshold; GC Score, GenCall score, 
LogR Dev, standard deviation of the logR ratio. 
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Figure 1. Correlation between qPCR ΔCT value and genotype missing rate 
 

